Clinical Trials Logo

Clinical Trial Summary

To get the visual outcomes for distance and intermediate and binocular defocus curve in patients with implanted monofocal intraocular lens Clareon (IOL; model SY60CL; Alcon Vision LLC) at 3 months after the surgery.


Clinical Trial Description

The goal of refractive cataract surgery is to remove the opacity, or cataract and to produce the desired refractive outcome. In most cases, the desired outcome is an emmetropic eye, or an eye that sees 20/20 Snellen for distance vision post-surgery with the implant of a monofocal IOL. This, however, does not offer much in the way of intermediate and near vision. The increased desire for simultaneous distance, intermediate and near vision has increased the popularity of multifocal IOLs (MIOLs). However MIOLs provide visual acuity for all distances, they has occurence of optical phenomena such as glare and halo and lower contrast sensitivity. Extended depth of focus (EDOF) lens should provide distance vision as good as monofocal lens and intermediate vision better than monofocal but without or with less appearance of optical phenomenon or decreased contrast sensitivity. This study is prospective, multi-center, conducted from 10/2022 to 08/2023 in the Ophthalmology department of Faculty Hospital Kralovske Vinohrady in Prague, in Eye Center Prague and Eye Clinic SOMICH (Karlovy Vary). The research protocol was explained to all participants and informed consent was signed before enrolling patient to the study. The study was approved by the Ethics Committee of Faculty Hospital Kralovske Vinohrady and will enrolled up to 100 patients with presence of cataract in both eyes. Bilateral clear corneal phacoemulsification and IOL implantation is performed by two experienced surgeon using the same technique in both eyes. The surgical process involved topical anesthesia, superior 3-step clear corneal incision (2,2mm), 5,0mm curvilinear capsulorhexis, phacoemulsification, bilateral irrigation- aspiration and implantation of monofocal aspheric intraocular lens (Clareon Alcon vision LLC). Patients are scheduled for visit at 3 months after the surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05697978
Study type Interventional
Source Faculty Hospital Kralovske Vinohrady
Contact Andrea Janekova, MD
Phone +420775727002
Email janekovaandrea@gmail.com
Status Recruiting
Phase N/A
Start date October 1, 2022
Completion date August 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05041881 - Long-term Comparative Analysis of Visual Outcomes With 3 Intraocular Lenses: Monofocal, Trifocal and Accommodating N/A
Completed NCT03157375 - Rotation of an Intraocular Lens - HOYA Vivinex iSert P261 N/A
Completed NCT04800887 - Visual Outcomes and Contrast Sensitivity in Patients Implanted With Tecnis Eyhance Intraocular Lens N/A
Not yet recruiting NCT05955846 - Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic N/A
Recruiting NCT05411341 - Comparison of Two Different Optical Biometric Systems
Recruiting NCT04927117 - Evaluation of Visual Acuity in Myopic Cataract Patients Using Trifocal Intraocular Lens
Completed NCT04557579 - Comparison of Quality of Vision After Bifocal and Extended Depth of Focus Intraocular Lens Implantation
Recruiting NCT03586271 - Comparison of the Visual Performance After Implantation of Multifocal Lens
Completed NCT06305338 - Predicting Intraocular Lens Tilt Using OCT Measurements and Partial Least Squares Regression Modelling
Completed NCT05262504 - Comparison of a Novel Non-diffractive Extended Depth of Focus Intraocular Lens (IOL) and a Trifocal IOL